Nature of preventable adverse drug events in hospitals: A literature review

American Journal of Health-System Pharmacy

Volumn 60, Issue 17, 2003, Pages 1750-1759

  Kanjanarat, Penkarn ^a,e   Winterstein, Almut G ^b   Johns, Thomas E ^b   Hatton, Randy C ^b,c   Gonzalez Rothi, Ricardo ^d   Segal, Richard ^b  

^a CHIANG MAI UNIVERSITY   (Thailand)

^b UNIVERSITY OF FLORIDA   (United States)

^c UMHHC   (United States)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

Allergies; Anticoagulants; Antiinfectives; Cardiovascular drugs; Dosage; Drugs, adverse reactions; Errors; Hospitals; Hypotensive agents; Medication; Opiates; Prescribing; Rational therapy; Warfarin

Indexed keywords

ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; CARDIOVASCULAR AGENT; OPIATE; WARFARIN; DRUG;

BLEEDING; BLOOD CLOTTING DISORDER; BRADYCARDIA; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; DRUG CLASSIFICATION; DRUG HYPERSENSITIVITY; DRUG OVERDOSE; DRUG SURVEILLANCE PROGRAM; HEMATOLOGIC DISEASE; HOSPITAL CARE; HUMAN; HYPOTENSION; KIDNEY DISEASE; LIVER DISEASE; MEDICATION ERROR; PAIN ASSESSMENT; PATIENT MONITORING; PRESCRIPTION; PREVENTIVE MEDICINE; PRIORITY JOURNAL; RESPIRATION DEPRESSION; REVIEW; UNSPECIFIED SIDE EFFECT; CLASSIFICATION; COMPARATIVE STUDY; FACTUAL DATABASE; HOSPITAL; HOSPITAL MANAGEMENT; RISK MANAGEMENT; STANDARD; STATISTICS; TREATMENT OUTCOME;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DATABASES, FACTUAL; HOSPITAL ADMINISTRATION; HOSPITALS; HUMANS; MEDICATION ERRORS; PHARMACEUTICAL PREPARATIONS; RISK MANAGEMENT; TREATMENT OUTCOME;

EID: 1542783234     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/60.17.1750     Document Type: Review

References (36)

1. Kohn LT, Corrigan JM, Donaldson MS, eds. To err is human: building a safer health system. Washington, DC: National Academy Press; 1999:1-15, 215-53.
2. Summary of information submitted to MedMARx in the year 2000. Rockville, MD: United States Pharmacopeial Convention; 2001.
3. Institute for Safe Medication Practices. ISMP medication safety alert. www. ismp.org/MSAarticles/recentarticIes.html (accessed 2002 Oct 10).
4. Joint Commission on Accreditation of Healthcare Organizations. Sentinel event alert, www.jcaho.org/about+us/news+ letters/sentinel+event+alert/sea_29. htm (accessed 2002 Aug 1).
5. McGuire HH Jr, Horsley JS 3rd, Salter DR et al. Measuring and managing quality of surgery. Statistical vs incidental approaches. Arch Surg. 1992; 127:733-7.
6. Beecher HK, Todd DP. A study of deaths associated with anesthesia and surgery. Ann Surg. 1955; 142:142-4.
7. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998; 279:1200-5.
8. Cullen DJ, Bates DW, Small SD et al. The incident reporting system does not detect adverse drug events: a problem for quality improvement. Jt Comm J Qual Improv. 1995; 21:541-8.
9. Brennan TA, Leape LL, Laird NM et al. Incidence of adverse events and negligence in hospitalized patients. Results from the Harvard Medical Practice Study I. N Engl J Med. 1991; 324:370-6.
10. Classen DC, Pestotnick SL, Evans RS et al. Computerized surveillance of adverse drug events in hospital patients. JAMA. 1991; 266:2847-51.
11. Raju TN, Kecskes S, Thornton JP et al. Medication errors in neonatal and paediatric intensive-care units. Lancet. 1989; 2:374-6.
12. Nolan L, O'Malley K. Prescribing for the elderly. Part I: sensitivity of the elderly to adverse drug reactions. J Am Geriatr Soc. 1988; 36:142-9.
13. Laventurier MF, Talley RB, Hefner DL et al. Drug utilization and potential drug-drug interactions. J Am Pharm Assoc. 1976; 16:77-81.
14. Bates DW, Boyle DL, Vander Vliet MB et al. Relationship between medication errors and adverse drug events. J Gen Intern Med. 1995; 10:199-205.
15. Bates DW, Cullen DJ, Laird N et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. JAMA. 1995; 274:29-34.
16. Cullen DJ, Sweitzer BJ, Bates DW et al. Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units. Crit Care Med. 1997; 25:1289-97.
17. Cullen DJ, Bates DW, Leape LL et al. Prevention of adverse drug events: a decade of progress in patient safety. J Clin Anesth. 2000; 12:600-14.
18. Thomas EJ, Brennan TA. Incidence and types of preventable adverse events in elderly patients: population based review of medical records. BMJ. 2000; 320:741-4.
19. Winterstein AG, Kanjanarat P, Johns T et al. Stimulated report of preventable adverse drug events related to commission and omission errors in hospital. Paper presented at Drug Information Association Meeting. Chicago, IL; 2002 Jun 17-20.
20. Barker KN, Flynn EA, Pepper GA et al. Medication errors observed in 36 health care facilities. Arch Intern Med. 2002; 162:1897-1903.
21. Pearson TF, Pittman DG, Longley JM et al. Factors associated with preventable adverse drug reactions. Am J Hosp Pharm. 1994; 51:2268-72.
22. Gholami K, Shalviri G. Factors associated with preventability, predictability, and severity of adverse drug reactions. Ann Pharmacother. 1999; 33:236-40.
23. Kaushal R, Bates DW, Landrigan C et al. Medication errors and adverse drug events in pediatric inpatients. JAMA. 2001; 285:2114-20.
24. Gray SL, Sager M, Lestico MR et al. Adverse drug events in hospitalized elderly. J Gerontol A Biol Sci Med Sci 1998; 53:M59-63.
25. Wilson RM, Runciman WB, Gibberd RW et al. The Quality in Australian Health Care Study. Med J Aust. 1995; 163:458-71.
26. Darchy B, Le Miere E, Figueredo B et al. Iatrogenic diseases as a reason for admission to the intensive care unit: incidence, causes, and consequences. Arch Intern Med. 1999; 159:71-8.
27. Thomas EJ, Studdert DM, Burstin HR et al. Incidence and types of adverse events and negligent care in Utah and Colorado. Med Care. 2000; 38:261-71.
28. Seeger JD, Kong SX, Schumock GT. Characteristics associated with ability to prevent adverse drug reactions in hospitalized patients. Pharmacotherapy. 1998; 18:1284-9.
29. Leape LL, Bates DW, Cullen DJ et al. Systems analysis of adverse drug events. JAMA. 1995; 274:35-43.
30. Lesar TS, Briceland L, Stein DS. Factors related to errors in medication prescribing. JAMA. 1997; 277:312-7.
31. Bratzler DW, Raskob GE, Murray CK et al. Underuse of venous thromboembolism prophylaxis for general surgery patients: physician practices in the community hospital setting. Arch Intern Med. 1998; 158:1909-12.
32. Goldhaber SZ, Dunn K, MacDougall RC. New onset of venous thromboembolism among hospitalized patients at Brigham and Women's hospital is caused more often by prophylaxis failure than by with-holding treatment. Chest. 2000; 118:1680-4.
33. Keane MG, Ingenito EP, Goldhaber SZ. Utilization of venous thromboembolism prophylaxis in the medical intensive care unit. Chest. 1994; 106:13-4.
34. Zanetti G, Giardina R, Platt R. Intraoperative redosing of cefazolin and risk for surgical site infection in cardiac surgery. Emerg Infect Dis. 2001; 7:828-31.
35. Spinler SA, Hilleman DE, Cheng JW et al. New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines. Ann Pharmacother. 2001; 35:589-617.
36. Winterstein AG, Sauer BC, Hepler CD et al. Preventable drug-related hospital admissions. Ann Pharmacother. 2002; 36:1238-48.